PGL 0.00% 85.0¢ prospa group limited.

options, page-3

  1. 160 Posts.
    Thanx for that PA. There are many knowledgeable posters here.

    I would also note the differences in drug delivery: Nexavar has a convenient pill formulation and for those of us that like a nice Pr-Ick there's PI-88.

    Remember that it is high time Progen acknowledged the competition with Nexavar widely expected to be approved for resectable liver treatment within months. Nexavar is the primary reason for the downtrend in the Progen sp and this should drive the valuation to slightly below cash backing. But dyor naturally
 
watchlist Created with Sketch. Add PGL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.